 Antiretroviral therapy combination interferon AIDS-related Kaposi sarcoma vitro studies zidovudine AZT replication human immunodeficiency virus type HIV peripheral blood mononuclear cells concentrations achievable patients Interferon alfa lesions patients acquired immunodeficiency syndrome AIDS Kaposi sarcoma KS zidovudine significant effect regression lesions antiviral activity patients decline serum HIV antigen drugs serious side effects patients addition development zidovudine-resistant strains patients advanced HIV disease zidovudine months vivo trials possible advantages combination therapy zidovudine interferon alfa patients AIDS-related KS incidence serious adverse reactions therapeutic efficacy rate emergence zidovudine-resistant strains HIV Preliminary results combination therapy interferon alfa zidovudine patients AIDS-related KS doses antitumor antiviral responses potential emergence zidovudine-resistant HIV strains